S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity

Dev Cell. 2021 Oct 25;56(20):2790-2807.e8. doi: 10.1016/j.devcel.2021.09.016. Epub 2021 Oct 1.

Abstract

SARS-CoV-2 virions are surrounded by a lipid bilayer that contains membrane proteins such as spike, responsible for target-cell binding and virus fusion. We found that during SARS-CoV-2 infection, spike becomes lipid modified, through the sequential action of the S-acyltransferases ZDHHC20 and 9. Particularly striking is the rapid acylation of spike on 10 cytosolic cysteines within the ER and Golgi. Using a combination of computational, lipidomics, and biochemical approaches, we show that this massive lipidation controls spike biogenesis and degradation, and drives the formation of localized ordered cholesterol and sphingolipid-rich lipid nanodomains in the early Golgi, where viral budding occurs. Finally, S-acylation of spike allows the formation of viruses with enhanced fusion capacity. Our study points toward S-acylating enzymes and lipid biosynthesis enzymes as novel therapeutic anti-viral targets.

Keywords: S-palmitoylation; SARS; ZDHHC; coronavirus; lipid microdomains; lipid sorting; spike; viral envelope; virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acylation / physiology*
  • Acyltransferases / metabolism
  • COVID-19 Drug Treatment*
  • Golgi Apparatus / metabolism
  • Golgi Apparatus / virology
  • Humans
  • Membrane Lipids / metabolism*
  • SARS-CoV-2 / pathogenicity*
  • Virus Assembly / physiology

Substances

  • Membrane Lipids
  • Acyltransferases
  • ZDHHC20 protein, human